These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 9345383)
21. Current developments in neurology, Part I: Advances in the pharmacotherapy of headache, epilepsy, and multiple sclerosis. Gidal BE; Wagner ML; Privitera MD; Dalmady-Israel C; Crismon ML; Fagan SC; Graves NM Ann Pharmacother; 1996 Nov; 30(11):1272-6. PubMed ID: 8913410 [TBL] [Abstract][Full Text] [Related]
22. [Current concepts on the use of some immunomodulatory drugs in the treatment of multiple sclerosis]. Correale J; Cristiano E Medicina (B Aires); 2001; 61(4):470-80. PubMed ID: 11563177 [TBL] [Abstract][Full Text] [Related]
23. Comparing the cost-effectiveness of disease-modifying drugs for the first-line treatment of relapsing-remitting multiple sclerosis. Goldberg LD; Edwards NC; Fincher C; Doan QV; Al-Sabbagh A; Meletiche DM J Manag Care Pharm; 2009 Sep; 15(7):543-55. PubMed ID: 19739877 [TBL] [Abstract][Full Text] [Related]
24. Disease-modifying drugs for the early treatment of multiple sclerosis. Flachenecker P Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542 [TBL] [Abstract][Full Text] [Related]
25. Interferon beta for multiple sclerosis. Connelly JF Ann Pharmacother; 1994 May; 28(5):610-6. PubMed ID: 8069001 [TBL] [Abstract][Full Text] [Related]
30. Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis. Richert ND; Ostuni JL; Bash CN; Leist TP; McFarland HF; Frank JA Mult Scler; 2001 Feb; 7(1):49-58. PubMed ID: 11321194 [TBL] [Abstract][Full Text] [Related]
31. [A short history of beta-interferon therapy of multiple sclerosis]. Stock G; Horowski R Med Klin (Munich); 2001 Sep; 96 Suppl 1():3-9. PubMed ID: 11603113 [TBL] [Abstract][Full Text] [Related]
33. [Immunotherapy of multiple sclerosis. Consensus and controversies]. Hohlfeld R Nervenarzt; 1999 Apr; 70(4):297. PubMed ID: 10354989 [No Abstract] [Full Text] [Related]
34. [The role of interferon beta in the treatment of multiple sclerosis]. Seeldrayers P Rev Med Brux; 1999 Sep; 20(4):A264-7. PubMed ID: 10523902 [TBL] [Abstract][Full Text] [Related]
35. [Current status of interferon beta-1b in multiple sclerosis therapy]. Hartung HP Med Klin (Munich); 2001 Sep; 96 Suppl 1():11-6. PubMed ID: 11603110 [TBL] [Abstract][Full Text] [Related]
38. [The use of beta-interferon-1b in children and adolescents with multiple sclerosis]. Bykova OV; Kuzenkova LM; Maslova OI Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(9):29-33. PubMed ID: 17069059 [TBL] [Abstract][Full Text] [Related]
39. Alternatives to current disease-modifying treatment in MS: what do we need and what can we expect in the future? Kappos L; Kuhle J; Gass A; Achtnichts L; Radue EW J Neurol; 2004 Sep; 251 Suppl 5():v57-v64. PubMed ID: 15549357 [TBL] [Abstract][Full Text] [Related]